Cancer Immunotherapy Meets Oncology In Honor of Christoph Huber /

This book provides a comprehensive update on the state of the art in cancer immunology, which has rapidly evolved from a field of clinical research into an established discipline of oncology. The key recent developments in immuno-oncology are all covered, from the ever-changing immunological and reg...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Britten, Cedrik Michael (Επιμελητής έκδοσης), Kreiter, Sebastian (Επιμελητής έκδοσης), Diken, Mustafa (Επιμελητής έκδοσης), Rammensee, Hans-Georg (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2014.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
Πίνακας περιεχομένων:
  • Immunological and Regulatory Framework for Immuno-Oncology: From Basic Immunology to New Therapies for Patients
  • How T cells single out tumor cells: 'and that has made all the difference'
  • Tregs and Immune Inhibition
  • Regulatory Landscape for Cancer Immunotherapy
  • Immunoguiding
  • Onco-Immunology Framework and Immunomodulatory Antibodies
  • Immunotherapies: Peptide-based Vaccines and HPV Malignancies.- Dendritic cell based cancer vaccines.- RNA Vaccines and Personalized Medicine Approaches.-Antibody Therapy in Oncology.- Engineered Antibodies to Engage Immune Cells to the Tumor
  • TCRs and TCR Therapy
  • CAR Therapy.- Cancer Entities: Melanoma
  • Prostate Cancer/Sipuleucel and RNA Vaccines
  • Recent advances in the immunotherapy of renal cell cancer and other solid tumors
  • Gastric Cancer
  • NSCLC
  • Breaking tolerance by allogeneic lymphocyte therapy.- Biomarkers: Exploring Immunogenic Cell Death for Patient Benefit
  • Circulating Tumor Cells
  • Genomics Meets Oncology
  • Featured Chapters: Oncolytic Viruses
  • Pharma View on Immunotherapy
  • Final Remarks.